First of all, let’s talk about the answer: do it!
Then why do it? In fact, the main reason is profit!
The increase in profit actually corresponds to two factors. The first is that the cost of drug research and development is increasing, and the second is that the price of drug demand at home and abroad has decreased. If you are not familiar with it, you can check the relevant content of drug price reduction for medical insurance.
With the development of the current medical level, the current R&D costs of the pharmaceutical industry, especially the R&D costs of new drugs, are getting higher and higher, and new drugs are also getting more and more difficult. For example, it only takes about 1 billion US dollars to develop a new drug in 2003. It is estimated that a new drug will be developed in 2011. It is estimated that a new drug will be developed in 2016. It is estimated that a new drug will be developed in 2021. It is expected that a new drug will be developed in 2021. The growth is too rapid.
cost is increasing year by year, and traditional small molecule new drugs have become fewer and fewer, and many pharmaceutical companies are also transforming towards gene therapy and biopharmaceutical development, and the R&D costs are often getting higher and higher.
Through digital transformation to , improve the speed of new drug research and development, and improve the R&D success rate, to ensure their own growth, is the most urgent and best way for pharmaceutical companies to do.
